Edwards Lifesciences Corp financial data

Symbol
EW on NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
One Edwards Way, Irvine, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
CVG CONTROLLED INC (to 1/21/2000)
Latest financial report
10-K - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 376 % +17%
Quick Ratio 76.6 % -6.59%
Debt-to-equity 33.7 % -17.1%
Return On Equity 48.6 % +125%
Return On Assets 36.4 % +136%
Operating Margin 25.4 % -2.99%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 588M shares -2.23%
Common Stock, Shares, Outstanding 589M shares -2.08%
Entity Public Float 55.5B USD -2.33%
Common Stock, Value, Issued 655M USD +0.66%
Weighted Average Number of Shares Outstanding, Basic 598M shares -1.48%
Weighted Average Number of Shares Outstanding, Diluted 599M shares -1.66%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 5.44B USD +8.57%
Research and Development Expense 1.05B USD +9.36%
Operating Income (Loss) 1.38B USD +5.33%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.55B USD +12.8%
Income Tax Expense (Benefit) 152M USD -0.2%
Net Income (Loss) Attributable to Parent 4.17B USD +198%
Earnings Per Share, Basic 6.98 USD/shares +202%
Earnings Per Share, Diluted 6.97 USD/shares +203%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.05B USD +169%
Accounts Receivable, after Allowance for Credit Loss, Current 609M USD -21.1%
Inventory, Net 1.09B USD +20.3%
Other Assets, Current 348M USD +54.6%
Assets, Current 6.29B USD +55.7%
Deferred Income Tax Assets, Net 992M USD +32.4%
Property, Plant and Equipment, Net 1.69B USD +5.97%
Operating Lease, Right-of-Use Asset 98.2M USD +16.4%
Intangible Assets, Net (Excluding Goodwill) 1.18B USD +195%
Goodwill 1.78B USD +55.2%
Other Assets, Noncurrent 722M USD +55.8%
Assets 13.1B USD +39.4%
Accounts Payable, Current 197M USD +5.79%
Employee-related Liabilities, Current 359M USD +13.3%
Liabilities, Current 1.51B USD +25.9%
Operating Lease, Liability, Noncurrent 78.9M USD +21%
Other Liabilities, Noncurrent 358M USD +42.3%
Liabilities 2.99B USD +13.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -245M USD -0.7%
Retained Earnings (Accumulated Deficit) 13.2B USD +46.4%
Stockholders' Equity Attributable to Parent 10B USD +50.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 10.1B USD +49.8%
Liabilities and Equity 13.1B USD +39.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -53.5M USD -117%
Net Cash Provided by (Used in) Financing Activities 61.7M USD
Net Cash Provided by (Used in) Investing Activities 63.1M USD +12520%
Common Stock, Shares Authorized 1.05B shares 0%
Common Stock, Shares, Issued 655M shares +0.66%
Common Stock, Par or Stated Value Per Share 1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 81M USD -22%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.06B USD +166%
Deferred Tax Assets, Valuation Allowance 87.8M USD +41.4%
Deferred Tax Assets, Gross 1.34B USD +45.1%
Operating Lease, Liability 102M USD +16.1%
Payments to Acquire Property, Plant, and Equipment 65.3M USD +6.18%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 4.17B USD +195%
Lessee, Operating Lease, Liability, to be Paid 114M USD +7.94%
Property, Plant and Equipment, Gross 2.48B USD +8.34%
Operating Lease, Liability, Current 23.4M USD +2.18%
Lessee, Operating Lease, Liability, to be Paid, Year Two 23.3M USD +18.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 26.4M USD -1.49%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11.9M USD +50.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.1M USD +17.2%
Deferred Tax Assets, Operating Loss Carryforwards 132M USD +74%
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 679M USD +16.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 13.2M USD +2.33%
Operating Lease, Payments 8.2M USD +15.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 38.5M USD +9.38%
Share-based Payment Arrangement, Expense 146M USD +16.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%